Smad3 Antibody

Skip to product information
1 of 2

Selleck Chemicals

SKU:F2851-20UL

Regular price €139,00 EUR
Regular price Sale price €139,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

Smad3, a key mediator of TGF-β signalling, transmits extracellular signals through its MH1 domain (binding DNA at GTCT/AGAC motifs) and MH2 domain (facilitating receptor interactions and Smad4 complex formation). Upon TGF-β binding to TβRII/TβRI receptors, Smad3 is phosphorylated at its C-terminal SSXS motif, causing a conformational change that releases autoinhibition and allows p300/CBP binding to activate genes like p21 (cell-cycle arrest) and PAI-1 (fibrosis).

Reported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following SMAD3 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

SMAD3 is commonly interpreted in the context of cancer, epigenetics, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between cytoplasm and nucleus across matched conditions
  • changes associated with proliferative state, oncogenic signaling, or treatment response
  • links between target behavior and transcriptional or chromatin-state changes
  • signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for SMAD3. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in SMAD3 reflect biology rather than handling. When interpreting SMAD3, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep SMAD3 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
SMAD3
Research Area:
Cancer • Cell Signaling • Epigenetics
Application:
FCM • IF • IHC • WB
Reactivity:
Human • Rat
Specificity:
Smad3 Antibody [H20E2] recognizes endogenous levels of total Smad3 protein.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
H20E2
UniProt:
P84022
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.